Association between postpartum depression and synthetic oxytocin use for postpartum hemorrhage prevention and treatment
| Autor: | Resul Karakuş, Çiğdem Pulatoğlu |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Postpartum depression
endocrine system medicine.medical_specialty business.industry Obstetrics Incidence (epidemiology) medicine.disease Oxytocin Obstetrics and Gynaecology Medicine Anxiety Surgery Pediatrics Perinatology and Child Health medicine.symptom Maternal anxiety business Maternal mood hormones hormone substitutes and hormone antagonists Depressive symptoms Depression (differential diagnoses) medicine.drug |
| Zdroj: | Zeynep Kamil Tıp Bülteni. 50:59-63 |
| ISSN: | 1300-7971 |
| Popis: | Objective:The aim of this study was to examine the relationship between postpartum synthetic oxytocin administration and the development of depressive and anxiety disorders after delivery.Materiyal and methods: We hypothesized that women exposed to postpartum exogenous oxytocin would have a reduced risk of postpartum depressive and anxiety disorders compared with those without exposure. The cases were examined under two groups as "Oxytocin users" (n = 100) and "Control" (n = 100) groups . Oxytocin group was given introvenous oxytocin just after the delivery for postpartum hemorrhage prevention and treatment. Questionnaires of depression and maternal anxiety were performed at the sixth week after the delivery. Results: The incidence of depression (4%) in the oxytocin group was significantly lower than the control group (14%) (p: 0.026, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|